{
  "id": "1b7e7160a9919bc4",
  "title": "Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U . S . FDA Approval of LEROCHOL\u2122 ( lerodalcibep - liga ) for Adults with Elevated LDL Cholesterol",
  "description": "20251217T090000Z",
  "content": "",
  "source": "thailand-business-news.com",
  "source_url": "https://www.thailand-business-news.com/pr-news/everest-medicines-announces-that-licensing-partner-lib-therapeutics-has-received-u-s-fda-approval-of-lerochol-lerodalcibep-liga-for-adults-with-elevated-ldl-cholesterol",
  "published_at": "20251217T090000Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Thailand",
  "raw_data": {
    "url": "https://www.thailand-business-news.com/pr-news/everest-medicines-announces-that-licensing-partner-lib-therapeutics-has-received-u-s-fda-approval-of-lerochol-lerodalcibep-liga-for-adults-with-elevated-ldl-cholesterol",
    "url_mobile": "",
    "title": "Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U . S . FDA Approval of LEROCHOL\u2122 ( lerodalcibep - liga ) for Adults with Elevated LDL Cholesterol",
    "seendate": "20251217T090000Z",
    "socialimage": "https://www.thailand-business-news.com/wp-content/uploads/2024/06/bangkok-river-skyline-sunset.avif",
    "domain": "thailand-business-news.com",
    "language": "English",
    "sourcecountry": "Thailand"
  }
}